Truepoint, Inc. Boston Scientific Corp Transaction History

Truepoint, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$48.64 - $57.81 $277,977 - $330,384	5,715 New	5,715 $330,000
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $139,146 - $246,239	-5,387 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$40.31 - $43.45 $22,452 - $24,201	557 Added 11.53%	5,387 $219,000
Q2 2019 Aug 08, 2019	SELL	$34.91 - $42.98 $110,106 - $135,558	-3,154 Reduced 39.5%	4,830 $208,000
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $7,766 - $9,617	236 Added 3.05%	7,984 $306,000
Q4 2018 Feb 13, 2019	BUY	$31.73 - $39.04 $245,844 - $302,481	7,748 New	7,748 $274,000

1,561

1.18B

6.78M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $146B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

Stay updated on Truepoint, Inc. with notifications on news.